Literature DB >> 18159370

A national survey of antimicrobial prophylaxis in adult cardiac surgery across Canada.

Fran L Paradiso-Hardy1, Patti Cornish, Chantal Pharand, Stephen E Fremes.   

Abstract

OBJECTIVE: To characterize national and regional patterns of antimicrobial prophylaxis in adult cardiac surgery across Canada.
DESIGN: Retrospective, cross-sectional analysis.
SETTING: Thirty-three adult cardiac surgical centres across Canada.
INTERVENTIONS: A one-page questionnaire collecting information regarding institutional demographics and antimicrobial prophylaxis regimens for adult cardiac surgical procedures was mailed to all adult surgical centres across Canada. If a response was not received within one month, a second survey was mailed, followed by a telephone reminder within two weeks of the second mailing. MAIN
RESULTS: The Overall response rate was 100%. Prophylactic antimicrobials were used in all the adult cardiac centres; single-agent prophylaxis was used in 97% (32 of 33) of centres; Single-dose antimicrobial prophylaxis was used in only 3% (one of 33) of centres. Preoperative and postoperative antimicrobial prophylaxis regimens varied both between provinces and within provinces across Canada. Cefazolin was the antimicrobial used in 88% (38 of 43) and 87% (33 of 38) of the reported pre-operative and post-operative prophylaxis regimens, respectively. Antimicrobial prophylaxis was initiated in the operating room 72% (26 of 36) of the time and intra-operative supplemental antimicrobial doses were administered for cardiac procedures longer than a median of 4 hours (range 4 to 8 hr). Overall, the median duration of antimicrobial prophylaxis was 36 hours (range 8 to 96 hr).
CONCLUSIONS: Despite the availability of various published guidelines, our survey identified several areas for improvement with respect to antimicrobial prophylaxis in adult cardiac surgery across Canada.

Entities:  

Keywords:  Antibiotics; Cardiac surgical procedures; Prophylaxis; Surgical wound infection

Year:  2002        PMID: 18159370      PMCID: PMC2094855          DOI: 10.1155/2002/370389

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  26 in total

1.  The economic implications of infection in cardiac surgery.

Authors:  R M Nelson; D J Dries
Journal:  Ann Thorac Surg       Date:  1986-09       Impact factor: 4.330

2.  Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery.

Authors:  S Vuorisalo; R Pokela; H Syrjälä
Journal:  Infect Control Hosp Epidemiol       Date:  1998-04       Impact factor: 3.254

Review 3.  Antimicrobial prophylaxis in surgery. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

Authors:  T K Waddell; O D Rotstein
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

4.  Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.

Authors:  A P Furnary; K J Zerr; G L Grunkemeier; A Starr
Journal:  Ann Thorac Surg       Date:  1999-02       Impact factor: 4.330

5.  Antibiotic prophylaxis in cardiothoracic surgery 1990: results of a third survey.

Authors:  M Woods; D Tillman
Journal:  Hosp Pharm       Date:  1992-05

6.  Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. The ESPRIT Group.

Authors:  R Saginur; D Croteau; M G Bergeron
Journal:  J Thorac Cardiovasc Surg       Date:  2000-12       Impact factor: 5.209

7.  Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial.

Authors:  D G Maki; M J Bohn; S M Stolz; G M Kroncke; C W Acher; P D Myerowitz
Journal:  J Thorac Cardiovasc Surg       Date:  1992-11       Impact factor: 5.209

8.  Clinical trial of cefamandole, cefazolin, and cefuroxime for antibiotic prophylaxis in cardiac operations.

Authors:  T R Townsend; B A Reitz; W B Bilker; J G Bartlett
Journal:  J Thorac Cardiovasc Surg       Date:  1993-10       Impact factor: 5.209

Review 9.  Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America.

Authors:  E P Dellinger; P A Gross; T L Barrett; P J Krause; W J Martone; J E McGowan; R L Sweet; R P Wenzel
Journal:  Clin Infect Dis       Date:  1994-03       Impact factor: 9.079

10.  Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.